"Millions of Americans are taking prescription drugs made in China and don't know it-- and pharmaceutical companies are not eager to tell them. This probing book examines the implications for the quality and availability of vital medicines for consumers"--Provided by publisher.

"American cartel is an unflinching and deeply documented dive into the culpability of the drug companies behind the staggering death toll of the opioid epidemic. It follows of a small band of DEA agents led by Joe Rannazzisi, a tough-talking New Yorker who had spent a storied 30 years bringing down bad guys, along with a band of lawyers led by West Virginia native Paul Farrell Jr. who fought to hold the drug industry to account in the face of the...

With her infant son's neuroblastoma in complete remission, famed medical examiner Laurie Montgomery struggles to regain her confidence as she returns to work after nearly two years of maternity leave. She takes on a seemingly routine case to ease herself back into the job: an unidentified Japanese male who died of what appears to be natural causes. But after hours of intense investigation, Laurie begins to suspect that her case was a victim of something...

When a canister of a deadly virus disappears and a lab technician starts bleeding from the eyes, Toni Gallo, the security director of a Scottish medical research firm, knows she has problems. When a Christmas Eve blizzard whips out of the north, a group meets in a remote family house: Stanley Oxenford, the research company's director, who has developed a drug to fight the virus; his children who have their eyes on the money it will bring; Toni Gallo...

"The Pharmaceutical Industry: Is Pharmaceutical Research Safe and Unbiased?; Are Prescription Drugs Appropriately Regulated?; Are Pharmaceutical Marketing Practices Ethical?; Is the Cost of Prescription Drugs in America Appropriate?"--Provided by publisher. Presents essays with opposing viewpoints on problems of drug testing, safety, regulation, and cost.

"When the application for a new sedative called Kevadon--commonly known as thalidomide--landed on Frances Kelsey's desk at the FDA in 1960, it seemed destined to sail through the review process. The drug, billed as entirely risk-free, was already being sold in forty-six countries. But when Kelsey learned that the drug caused terrible birth defects, she and a team of dedicated doctors, parents, and journalists fought Merrell, the drug's American manufacturer,...

At the beginning of 2020, McCullough was a program director at a major academic medical center in Dallas, Texas. Searching for a treatment for the disease, he followed the longstanding principle that it is best to tackle a sickness early. McCullough and his colleagues developed an early treatment protocol-- which was not welcomed by public health officials. News of their promising results was dismissed; McCullough and his colleagues were attacked...